APA (7th ed.) Citation

K, B., BD, C., AI, R., M, Y., E, N., M, M., . . . JB, G. (2019). Polypharmacy is associated with treatment response and serious adverse events: Results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis. Rheumatology (Oxford, England), 58(10), 1767. https://doi.org/10.1093/rheumatology/kez037

Chicago Style (17th ed.) Citation

K, Bechman, et al. "Polypharmacy Is Associated with Treatment Response and Serious Adverse Events: Results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis." Rheumatology (Oxford, England) 58, no. 10 (2019): 1767. https://doi.org/10.1093/rheumatology/kez037.

MLA (9th ed.) Citation

K, Bechman, et al. "Polypharmacy Is Associated with Treatment Response and Serious Adverse Events: Results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis." Rheumatology (Oxford, England), vol. 58, no. 10, 2019, p. 1767, https://doi.org/10.1093/rheumatology/kez037.